Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response
From MaRDI portal
Publication:2115998
Abstract: tBregs are a newly discovered subcategory of B regulatory cells, which are generated by breast cancer, resulting in the increase of Tregs and therefore in the death of NK cells. In this study, we use a mathematical and computational approach to investigate the complex interactions between the aforementioned cells as well as CD8 T cells, CD4 T cells and B cells. Furthermore, we use data fitting to prove that the functional response regarding the lysis of breast cancer cells by NK cells has a ratio-dependent form. Additionally, we include in our model the concentration of rituximab - a monoclonal antibody that has been suggested as a potential breast cancer therapy - and test its effect, when the standard, as well as experimental dosages, are administered.
Recommendations
- A mathematical study of the role of tbregs in breast cancer
- Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment
- Mathematical modelling of the inhibitory role of regulatory T cells in tumor immune response
- Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer
- Role of regulatory T cells on a simple tumor-immune interaction system
Cites work
- A comparison and catalog of intrinsic tumor growth models
- A mathematical model of tumor-immune interactions
- B cell chronic lymphocytic leukemia - a model with immune response
- CAR T cell therapy in B-cell acute lymphoblastic leukaemia: insights from mathematical models
- Cancer immunotherapy, mathematical modeling and optimal control
- Mathematical model creation for cancer chemo-immunotherapy
- Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment
- Mathematical modeling on helper T cells in a tumor immune system
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions
- NeuralPDE.jl
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Periodically pulsed immunotherapy in a mathematical model of tumor, CD4^+ T cells, and antitumor cytokine interactions
- Qualitative behavior of systems of tumor-\(\mathrm{CD}4^{+}\)-cytokine interactions with treatments
Cited in
(7)- On a moving boundary problem associated with a mathematical model of breast cancer
- Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma
- Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters
- Dynamic analysis of a drug resistance evolution model with nonlinear immune response
- B7-H1 and a mathematical model for cytotoxic T cell and tumor cell interaction
- A mathematical study of the role of tbregs in breast cancer
- Mathematical modelling of trastuzumab-induced immune response in an \textit{in vivo} murine model of HER2+ breast cancer
This page was built for publication: Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2115998)